Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Autor: Greenberg, Peter L., Sun, Zhuoxin, Miller, Kenneth B., Bennett, John M., Tallman, Martin S., Dewald, Gordon, Paietta, Elisabeth, van der Jagt, Richard, Houston, Jessie, Thomas, Mary L., Cella, David, Rowe, Jacob M.
Zdroj: In Blood 17 September 2009 114(12):2393-2400
Databáze: ScienceDirect